Pharmacological treatments in ARDS; a state-of-the-art update

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Boyle, Andrew J ^a,b   Sweeney, Rob M ^b   McAuley, Daniel F ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Acute lung injury; Acute respiratory distress syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA INTERFERON; CISATRACURIUM; CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; HEPARIN; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KERATINOCYTE GROWTH FACTOR; LEUKOCYTE ELASTASE INHIBITOR; METHYLPREDNISOLONE; NITRIC OXIDE; PALIFERMIN; PLACEBO; PROSTACYCLIN; ROSUVASTATIN; SALBUTAMOL; SIMVASTATIN; SIVELESTAT; SURFACTANT; VASCULOTROPIN INHIBITOR; VITAMIN D;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ART; ARTIFICIAL VENTILATION; CORTICOSTEROID THERAPY; DRUG MEGADOSE; ESOPHAGUS RESECTION; EXPERIMENTAL MODEL; EXTUBATION; FLUID BALANCE; HUMAN; INCIDENCE; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NEUROMUSCULAR BLOCKING; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; SEPSIS; SEPTIC SHOCK; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 84884961175     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-166     Document Type: Review

References (41)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
2. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693. 10.1056/NEJMoa022450, 12594312.
3. Ashbaugh D, Boyd Bigelow D, Petty T, Levine B. Acute respiratory distress in adults. Lancet 1967, 290:319-323.
4. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. The Acute Respiratory Distress Syndrome Network.
5. Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal J-M, Perez D, Seghboyan J-M, Constantin J-M, Courant P, Lefrant J-Y, Guérin C, Prat G, Morange S, Roch A. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363:1107-1116. 10.1056/NEJMoa1005372, 20843245.
6. Perkins GD, McAuley DF, Thickett DR, Gao F. The β-Agonist Lung Injury Trial (BALTI) a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
7. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Randomized, placebo-controlled clinical trial of an aerosolized β2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184:561-568. 3175548, 21562125, The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
8. Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE. Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012, 379:229-235. 10.1016/S0140-6736(11)61623-1, 3266479, 22166903.
9. Zeiher BG, Artigas A, Vincent J-L, Dmitrienko A, Jackson K, Thompson BT, Bernard G. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004, 32:1695-1702. 10.1097/01.CCM.0000133332.48386.85, 15286546.
10. Iwata K, Doi A, Ohji G, Oka H, Oba Y, Takimoto K, Igarashi W, Gremillion DH, Shimada T. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med 2010, 49:2423-2432. 10.2169/internalmedicine.49.4010, 21088343.
11. Weigelt JA, Norcross JF, Borman KR, Snyder WH. Early steroid therapy for respiratory failure. Arch Surg 1985, 120:536-540. 10.1001/archsurg.1985.01390290018003, 3885915.
12. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M. The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 1984, 311:1137-1143. 10.1056/NEJM198411013111801, 6384785.
13. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138:62-68. 10.1164/ajrccm/138.1.62, 3202402.
14. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354:1671-1684. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
15. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007, 131:954-963. 10.1378/chest.06-2100, 17426195.
16. Deal EN, Hollands JM, Schramm GE, Micek ST. Role of corticosteroids in the management of acute respiratory distress syndrome. Clin Ther 2008, 30:787-799. 10.1016/j.clinthera.2008.05.012, 18555927.
17. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008, 336:1006-1009. 10.1136/bmj.39537.939039.BE, 2364864, 18434379.
18. Shyamsundar M, McKeown STW, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009, 179:1107-1114. 10.1164/rccm.200810-1584OC, 2695496, 19324974.
19. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med 2011, 183:620-626. 10.1164/rccm.201003-0423OC, 20870757.
20. McAuley DF, Laffey JG, O'Kane CM, Cross M, Perkins GD, Murphy L, McNally C, Crealey G, Stevenson M, the HARP-2 investigators on behalf of the Irish Critical Care Trials Group Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial. Trials 2012, 13:170. 10.1186/1745-6215-13-170, 3543316, 22985805, the HARP-2 investigators on behalf of the Irish Critical Care Trials Group.
21. Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care 2010, 14:R180. 10.1186/cc9286, 3219284, 20937093.
22. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011, 139:289-295. 10.1378/chest.10-0891, 3032365, 20688925.
23. Kor DJ, Erlich J, Gong MN, Malinchoc M, Carter RE, Gajic O, Talmor DS. Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med 2011, 39:2393-2400. 10.1097/CCM.0b013e318225757f, 3196806, 21725238.
24. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui C-C, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436:112-116. 10.1038/nature03712, 16001071.
25. Yao S, Feng D, Wu Q, Li K, Wang L. Losartan attenuates ventilator-induced lung injury. J Surg Res 2008, 145:25-32. 10.1016/j.jss.2007.03.075, 17688881.
26. Noveanu M, Breidthardt T, Reichlin T, Gayat E, Potocki M, Pargger H, Heise A, Meissner J, Twerenbold R, Muravitskaya N, Mebazaa A, Mueller C. Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study. Crit Care 2010, 14:R198. 10.1186/cc9317, 3219994, 21047406.
27. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012, 18:759-765. 10.1038/nm.2736, 3727429, 22504485.
28. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007, 179:1855-1863.
29. Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013, 187:751-760. 10.1164/rccm.201206-0990OC, 23292883.
30. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002, 282:L924-L940.
31. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med 2010, 38:S569-S573. 3580946, 21164399.
32. Cross LJ, O'Kane CM, McDowell C, Elborn JJ, Matthay MA, McAuley DF. Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol. Trials 2013, 14:51. 10.1186/1745-6215-14-51, 3620926, 23419093.
33. Takano Y, Mitsuhashi H, Ueno K. 1α,25-dihydroxyvitamin D3 inhibits neutrophil recruitment in hamster model of acute lung injury. Steroids 2011, 76:1305-1309. 10.1016/j.steroids.2011.06.009, 21745487.
34. Parekh D, Dancer RC, Lax S, Cooper MS, Martineau AR, Fraser WD, Tucker O, Alderson D, Perkins GD, Gao-Smith F, Thickett DR. Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial. Trials 2013, 14:100. 10.1186/1745-6215-14-100, 3680967, 23782429.
35. Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M. IFN-β protects from vascular leakage via up-regulation of CD73. Eur J Immunol 2007, 37:3334-3338. 10.1002/eji.200737793, 18034430.
36. Ware LB, Kaner RJ, Crystal RG, Schane R, Trivedi NN, McAuley D, Matthay MA. VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema. Eur Respir J 2005, 26:101-105. 10.1183/09031936.05.00106604, 2757043, 15994395.
37. Adhikari NKJ, Burns KEA, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007, 334:779-779. 10.1136/bmj.39139.716794.55, 1852043, 17383982.
38. Afshari A, Brok J, Møller AM, Wetterslev J. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Cochrane Database Syst Rev 2010, CD007733.
39. Spragg RG, Taut FJH, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Günther A. Recombinant Surfactant Protein C-based Surfactant for Patients with Severe Direct Lung Injury. Am J Respir Crit Care Med 2011, 183:1055-1061. 10.1164/rccm.201009-1424OC, 21148720.
40. Mac Sweeney R, McAuley DF. Pharmacological therapy for acute lung injury. Open Crit Care Med J 2010, 3:7-19.
41. Raghavendran K, Pryhuber GS, Chess PR, Davidson BA, Knight PR, Notter RH. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem 2008, 15:1911-1924. 10.2174/092986708785132942, 2636692, 18691048.